Liver ultrasound in cirrhosis is inadequate for hepatocellular carcinoma surveillance compared to magnetic resonance imaging
Open Access
- 6 June 2022
- journal article
- research article
- Published by Wiley in Liver Cancer International
- Vol. 3 (3) , 113-118
Abstract
Background: The guidelines recommend surveillance with liver ultrasound (US) for early detection of hepatocellular carcinoma (HCC). The accuracy of US is operator‐dependent and is limited in those with severe obesity or ascites. Magnetic resonance imaging (MRI) may have higher accuracy for detecting HCC, especially early HCC.Objective: To assess the accuracy of US for HCC detection using MRI as the clinical gold standard.Methods: We performed a retrospective study of 223 patients with cirrhosis who had both abdominal US and MRI within 6 months of each other, between October 2013 and November 2018. Using MRI as the gold standard for detecting HCC, the test characteristics of US and concordance with MRI were evaluated, and potential patient characteristics associated with the false‐negative US were examined.Results: Of 223 patients, MRI detected HCC in 70 patients while US detected HCC only in 38; thus, the overall sensitivity of US was 54% in detecting HCC, using MRI as the reference standard. The prevalence‐adjusted and bias‐adjusted kappa (PABAK) was 0.65 for the entire group. However, PABAK was only 0.04 when the subgroup with HCC (n = 70) was analysed. Higher Model for End‐Stage Liver Disease (MELD) score was the only factor that was associated with decreased US sensitivity, with the odds of false‐negative US increasing by 9.8% for each 1‐point increase in MELD.Conclusion: Our study showed that MRI performed better than the US in detecting HCC in patients with cirrhosis. Patients with higher MELD may require an MRI for HCC surveillance for early diagnosis of HCC.Keywords
This publication has 32 references indexed in Scilit:
- LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directionsHepatology, 2014
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysisPLOS Medicine, 2014
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.Hepatology, 2013
- Impact of gadoxetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance on the non‐invasive diagnosis of small hepatocellular carcinoma: a prospective studyAlimentary Pharmacology & Therapeutics, 2012
- Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRIBritish Journal of Radiology, 2012
- Measuring agreement of administrative data with chart data using prevalence unadjusted and adjusted kappaBMC Medical Research Methodology, 2009
- Randomized controlled trial of screening for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2004
- Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patientsEuropean Radiology, 2003
- Sonographic Detection of Hepatocellular Carcinoma and Dysplastic Nodules in Cirrhosis: Correlation of Pretransplantation Sonography and Liver Explant Pathology in 200 PatientsAmerican Journal of Roentgenology, 2002
- Prospective study of early detection for primary liver cancerJournal of Cancer Research and Clinical Oncology, 1997